Tuesday, March 9, 2010

FDA Approves New Drug For Advanced Liver Cancer

October 20, 2009 by Patrick Comer  
Filed under Healthcare

The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005.
Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow and survive.
Votrient is intended for people with advanced renal cell carcinoma, a type of [...]